NU 641
Women’s Health for the AGPCNP
Finals Exam Review (Qns & Ans)
2025
1. Multiple Choice
Question: A 55-year-old postmenopausal woman presents with
vaginal bleeding. What is the most appropriate next step in her
management?
A. Start hormone replacement therapy
B. Perform a pelvic ultrasound to assess endometrial thickness
C. Prescribe antibiotics for possible infection
D. Recommend endometrial biopsy only if symptoms persist
ANS: B
©2025
, Rationale: Postmenopausal bleeding warrants evaluation of
endometrial thickness via pelvic ultrasound to rule out
endometrial hyperplasia or malignancy.
---
2. Fill-in-the-Blank
Question: The recommended screening interval for cervical
cancer in women aged 30–65 years with co-testing (HPV and
cytology) is every ____________ years if results are normal.
ANS: 5
Rationale: Women aged 30–65 years may undergo cervical
cancer screening with co-testing every five years, provided results
are negative.
---
3. True/False
Question: Hormonal contraceptives are contraindicated in
women with a history of thromboembolic events.
ANS: True
©2025
, Rationale: Hormonal contraceptives, particularly those
containing estrogen, increase the risk of thrombosis and are
contraindicated in such patients.
---
4. Multiple Response
Question: Which lifestyle modifications are recommended to
reduce the risk of osteoporosis in postmenopausal women? (Select
all that apply)
- A. Weight-bearing exercises
- B. Increasing dietary calcium intake
- C. Smoking cessation
- D. Reducing fluid intake
ANS: A, B, C
Rationale: Weight-bearing exercises, adequate calcium intake,
and smoking cessation improve bone health. Reducing fluid
intake does not impact osteoporosis risk.
---
©2025
, 5. Multiple Choice
Question: Which pharmacological treatment is recommended
as first-line for vulvovaginal atrophy in postmenopausal women?
A. Topical estrogen therapy
B. Systemic estrogen-progestin therapy
C. Oral antibiotics
D. Antihistamines
ANS: A
Rationale: Topical estrogen effectively addresses symptoms of
vulvovaginal atrophy with minimal systemic absorption.
---
6. Fill-in-the-Blank
Question: ____________ is the leading cause of infertility in
women and is commonly associated with irregular ovulation and
hyperandrogenism.
ANS: Polycystic Ovary Syndrome (PCOS)
Rationale: PCOS is a common endocrine disorder causing
anovulation, hyperandrogenism, and infertility in women.
©2025
Women’s Health for the AGPCNP
Finals Exam Review (Qns & Ans)
2025
1. Multiple Choice
Question: A 55-year-old postmenopausal woman presents with
vaginal bleeding. What is the most appropriate next step in her
management?
A. Start hormone replacement therapy
B. Perform a pelvic ultrasound to assess endometrial thickness
C. Prescribe antibiotics for possible infection
D. Recommend endometrial biopsy only if symptoms persist
ANS: B
©2025
, Rationale: Postmenopausal bleeding warrants evaluation of
endometrial thickness via pelvic ultrasound to rule out
endometrial hyperplasia or malignancy.
---
2. Fill-in-the-Blank
Question: The recommended screening interval for cervical
cancer in women aged 30–65 years with co-testing (HPV and
cytology) is every ____________ years if results are normal.
ANS: 5
Rationale: Women aged 30–65 years may undergo cervical
cancer screening with co-testing every five years, provided results
are negative.
---
3. True/False
Question: Hormonal contraceptives are contraindicated in
women with a history of thromboembolic events.
ANS: True
©2025
, Rationale: Hormonal contraceptives, particularly those
containing estrogen, increase the risk of thrombosis and are
contraindicated in such patients.
---
4. Multiple Response
Question: Which lifestyle modifications are recommended to
reduce the risk of osteoporosis in postmenopausal women? (Select
all that apply)
- A. Weight-bearing exercises
- B. Increasing dietary calcium intake
- C. Smoking cessation
- D. Reducing fluid intake
ANS: A, B, C
Rationale: Weight-bearing exercises, adequate calcium intake,
and smoking cessation improve bone health. Reducing fluid
intake does not impact osteoporosis risk.
---
©2025
, 5. Multiple Choice
Question: Which pharmacological treatment is recommended
as first-line for vulvovaginal atrophy in postmenopausal women?
A. Topical estrogen therapy
B. Systemic estrogen-progestin therapy
C. Oral antibiotics
D. Antihistamines
ANS: A
Rationale: Topical estrogen effectively addresses symptoms of
vulvovaginal atrophy with minimal systemic absorption.
---
6. Fill-in-the-Blank
Question: ____________ is the leading cause of infertility in
women and is commonly associated with irregular ovulation and
hyperandrogenism.
ANS: Polycystic Ovary Syndrome (PCOS)
Rationale: PCOS is a common endocrine disorder causing
anovulation, hyperandrogenism, and infertility in women.
©2025
